- Trading turnover of CHF 93.6 billion (+18.0% month-on-month)
- Number of trades 4,706,922 (-0.2% month-on-month)
- SMI® index at 11,127.8 points at the end of November (+2.8% month-on-month)
After eleven months of the year 2022, trading turnover on SIX Swiss Exchange reached a total of CHF 1,128.6 billion, 4.6% less than in the corresponding period in 2021, while the number of transactions was 2.1% lower with a total of 56,842,448.
The highest turnover on a single trading day was recorded on 30 November, which saw securities worth a total volume of CHF 8.8 billion changing hands. The highest number of trades was recorded on 11 November, with 320,121.
The stock that generated the highest turnover during the reporting month was ROCHE GS with CHF 8.8 billion; NOVARTIS N was the most traded stock with 314,705 transactions.
In November, products with crypto currencies as underlyings reached a trading turnover of CHF 126.9 million (+84.5% compared to October). In total, 209 products were traded and 10,483 transactions concluded (+120.7%). The highest turnover was recorded by AETH, an ETP on Ethereum, with CHF 26.4 million; the most transactions were also recorded by AETH, with 2,551 trades.
Detailed statistics on turnover and transaction volumes per segment compared with the previous month and previous year, on newly listed products and on the development of the most important indices can be found in the tables below. The website of SIX Swiss Exchange provides you with full access to our complete information offering. We provide you with the latest market data and comprehensive statistics for our entire securities universe. This includes order book information, prices, volumes and turnover figures as well as historical data and statistics. We also provide official notices of listed companies, management transactions and other relevant information to ensure safe and transparent trading. Discover more.
November 2022 |
Trading days: 22 |
Trading days in previous month: 21 |
---|---|---|
Segment |
Turnover in CHF million | Change versus previous month |
Equities incl. Funds + ETPs* | 71,861 | 17.3% |
Bonds CHF | 12,980 | 11.4% |
ETFs | 6,514 | 74.9% |
Bonds non-CHF | 1,424 | -21.2% |
Structured products and warrants | 819 | -1.3% |
TOTAL | 93,598 | 18.0% |
|
Number of trades | Change versus previous month |
Equities incl. Funds + ETPs* | 4,517,312 | -0.2% |
Bonds CHF | 35,586 | 15.1% |
ETFs | 117,297 | -4.1% |
Bonds non-CHF | 1,595 | -25.9% |
Structured products and warrants | 35,132 | -4.1% |
TOTAL | 4,706,922 | -0.2% |
Number of newly listed products |
Change versus previous month | |
Bonds CHF | 33 | 73.7% |
Structured products and warrants | 11,657 | 14.3% |
Since beginning of 2022 |
Trading days since beginning of 2022: 233 |
Trading days in same prior-year period: 233 |
---|---|---|
Segment |
Turnover in CHF million | Change versus same prior-year period |
Equities incl. Funds + ETPs* | 883,115 | -8.8% |
Bonds CHF | 130,002 | 20.1% |
ETFs | 90,329 | 27.2% |
Bonds non-CHF | 13,701 | -18.7% |
Structured products and warrants | 11,487 | -37.9% |
TOTAL | 1,128,635 | -4.6% |
|
Number of trades |
Change versus same prior-year period |
Equities incl. Funds + ETPs* | 54,480,678 | -1.9% |
Bonds CHF | 284,406 | 25.3% |
ETFs | 1,560,644 | -2.5% |
Bonds non-CHF | 15,252 | 23.5% |
Structured products and warrants | 501,468 | -30.9% |
TOTAL | 56,842,448 | -2.1% |
Number of newly listed products |
Change versus previous month | |
Bonds CHF | 325 | 2.2% |
Structured products and warrants | 85,801 | 64.0% |
Index |
Month-end reading |
Change versus end of previous month |
Change since end of last year |
---|---|---|---|
SMI® PR | 11,127.8 | 2.8% | -13.6% |
SLI Swiss Leader Index® PR | 1,700.5 | 4.2% | -17.8% |
SMIM® PR | 2,528.6 | 4.5% | -26.5% |
SPI® TR | 14,199.5 | 2.9% | -13.7% |
SPI EXTRA® TR | 4,727.5 | 4.7% | -22.9% |
SXI LIFE SCIENCES® TR | 6,389.7 | 3.8% | -24.0% |
SXI Bio+Medtech® TR | 5,224.7 | 3.7% | -25.7% |
SBI® AAA-BBB Total Return | 125.8 | 1.5% | -9.7% |
More detailed information
Please do not hesitate to contact Julian Chan.